Louisiana State Employees Retirement System Acquires 300 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Louisiana State Employees Retirement System raised its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 3.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 10,300 shares of the medical instruments supplier’s stock after acquiring an additional 300 shares during the quarter. Louisiana State Employees Retirement System’s holdings in ICU Medical were worth $1,223,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of ICUI. Lecap Asset Management Ltd. acquired a new stake in ICU Medical in the second quarter valued at $348,000. Kirr Marbach & Co. LLC IN grew its position in shares of ICU Medical by 5.6% in the 2nd quarter. Kirr Marbach & Co. LLC IN now owns 23,809 shares of the medical instruments supplier’s stock valued at $2,827,000 after buying an additional 1,269 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of ICU Medical by 3.2% during the second quarter. Nisa Investment Advisors LLC now owns 10,939 shares of the medical instruments supplier’s stock worth $1,299,000 after acquiring an additional 339 shares during the last quarter. Blue Trust Inc. raised its position in shares of ICU Medical by 384.4% during the second quarter. Blue Trust Inc. now owns 1,090 shares of the medical instruments supplier’s stock worth $129,000 after acquiring an additional 865 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier’s stock worth $691,000 after acquiring an additional 4,744 shares during the period. Institutional investors own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

ICUI has been the subject of a number of recent analyst reports. KeyCorp increased their target price on shares of ICU Medical from $136.00 to $147.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Raymond James increased their price objective on shares of ICU Medical from $135.00 to $158.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Thursday, August 8th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $138.33.

ICU Medical Stock Down 0.4 %

ICUI stock opened at $162.87 on Tuesday. ICU Medical, Inc. has a 1-year low of $78.28 and a 1-year high of $165.15. The stock has a market cap of $3.97 billion, a P/E ratio of -66.48 and a beta of 0.69. The stock’s fifty day simple moving average is $130.94 and its two-hundred day simple moving average is $113.01. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 EPS for the quarter, topping the consensus estimate of $1.00 by $0.56. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The business had revenue of $596.50 million for the quarter, compared to analyst estimates of $556.64 million. During the same quarter in the previous year, the firm posted $1.58 earnings per share. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. Analysts expect that ICU Medical, Inc. will post 3.5 EPS for the current year.

Insider Transactions at ICU Medical

In related news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,320,691.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,320,691.72. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the transaction, the vice president now owns 4,482 shares of the company’s stock, valued at $645,901.02. The disclosure for this sale can be found here. Insiders sold 26,589 shares of company stock worth $3,471,335 over the last quarter. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.